114 related articles for article (PubMed ID: 8626138)
21. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
[TBL] [Abstract][Full Text] [Related]
22. Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2.
Schuyer M; van der Burg ME; Henzen-Logmans SC; Fieret JH; Klijn JG; Look MP; Foekens JA; Stoter G; Berns EM
Br J Cancer; 2001 Nov; 85(9):1359-67. PubMed ID: 11720475
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
Stavropoulos NE; Filiadis I; Ioachim E; Hastazeris K; Tsimaris I; Kalogeras D; Stefanaki S; Agnantis NJ
Anticancer Res; 2002; 22(6B):3759-64. PubMed ID: 12552989
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma.
Mooy CM; Luyten GP; de Jong PT; Luider TM; Stijnen T; van de Ham F; van Vroonhoven CC; Bosman FT
Am J Pathol; 1995 Oct; 147(4):1097-104. PubMed ID: 7573354
[TBL] [Abstract][Full Text] [Related]
25. Prognostic relevance of Ki-67 antigen and c-myc oncoprotein in malignant fibrous histocytoma.
Brinck U; Stachura J; Kellner S; Schauer A
Anticancer Res; 1995; 15(5B):1915-9. PubMed ID: 8572578
[TBL] [Abstract][Full Text] [Related]
26. Smooth muscle tumors of the gastrointestinal tract. Expression of ras P21 oncogene product and the association with clinicopathology.
Cai JH; Jiang YK; Zhang YY; Lu GH; Zhang XH; Gao QZ; Zuo LF
Chin Med J (Engl); 1994 Sep; 107(9):683-7. PubMed ID: 7805461
[TBL] [Abstract][Full Text] [Related]
27. p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas.
Pagnano KB; Vassallo J; Lorand-Metze I; Costa FF; Saad ST
Am J Hematol; 2001 Jun; 67(2):84-92. PubMed ID: 11343379
[TBL] [Abstract][Full Text] [Related]
28. [Quantitation of Ras p21 oncogene and DNA content of gastrointestinal smooth muscle tumors and prognostic significance].
Cai J; Jiang Y; Zhang Y
Zhonghua Wai Ke Za Zhi; 1995 Apr; 33(4):225-8. PubMed ID: 7587676
[TBL] [Abstract][Full Text] [Related]
29. Correlation of c-myc expression with nuclear pleomorphism in human renal cell carcinoma.
Kinouchi T; Saiki S; Naoe T; Uenaka A; Kotake T; Shiku H; Nakayama E
Cancer Res; 1989 Jul; 49(13):3627-30. PubMed ID: 2659164
[TBL] [Abstract][Full Text] [Related]
30. Preliminary study on oncogene product immunohistochemistry (c-erbB-2, c-myc, ras p21, EGFR) in breast pathology.
Saccani Jotti G; Fontanesi M; Bombardieri E; Gabrielli M; Veronesi P; Bianchi M; Becchi G; Bogni A; Tardini A
Int J Biol Markers; 1992; 7(1):35-42. PubMed ID: 1349907
[TBL] [Abstract][Full Text] [Related]
31. Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Sullivan S; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):18-24. PubMed ID: 9454654
[TBL] [Abstract][Full Text] [Related]
32. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior.
Costa MJ; Walls J; Ames P; Roth LM
Hum Pathol; 1996 Mar; 27(3):274-81. PubMed ID: 8600043
[TBL] [Abstract][Full Text] [Related]
33. [Amplification of proto-oncogenes C-myc, C-N-ras, C-Ki-ras, C-erbB2 in ovarian carcinoma].
Bian M; Fan Q; Huang S
Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):406-9. PubMed ID: 7587576
[TBL] [Abstract][Full Text] [Related]
34. [Flow cytometric analysis of oncogene products].
Tsuchiya H
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2352-9. PubMed ID: 2665653
[TBL] [Abstract][Full Text] [Related]
35. Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells.
Motohara T; Masuko S; Ishimoto T; Yae T; Onishi N; Muraguchi T; Hirao A; Matsuzaki Y; Tashiro H; Katabuchi H; Saya H; Nagano O
Carcinogenesis; 2011 Nov; 32(11):1597-606. PubMed ID: 21828057
[TBL] [Abstract][Full Text] [Related]
36. The early response of p53-dependent proteins during radiotherapy in human rectal carcinoma and in adjacent normal tissue.
Stift A; Prager G; Selzer E; Widder J; Kandioler D; Friedl J; Teleky B; Herbst F; Wrba F; Bergmann M
Int J Oncol; 2003 Nov; 23(5):1269-75. PubMed ID: 14532965
[TBL] [Abstract][Full Text] [Related]
37. p53 and mdm-2 expression in Rhabdomyosarcoma of childhood and adolescence: clinicopathologic study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study.
Leuschner I; Langhans I; Schmitz R; Harms D; Mattke A; Treuner J;
Pediatr Dev Pathol; 2003; 6(2):128-36. PubMed ID: 12574910
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical detection of c-myc oncoprotein in paraffin embedded tissues.
Pavelic K; Pavelic ZP; Denton D; Reising J; Khalily M; Preisler HD
J Exp Pathol; 1990; 5(4):143-53. PubMed ID: 2101132
[TBL] [Abstract][Full Text] [Related]
39. Expression of p21 ras oncoproteins in human cancers.
Tanaka T; Slamon DJ; Battifora H; Cline MJ
Cancer Res; 1986 Mar; 46(3):1465-70. PubMed ID: 3510727
[TBL] [Abstract][Full Text] [Related]
40. Mitotic catastrophe in malignant epithelial tumors: the pathologist's viewpoint.
Caruso R; Fedele F; Lucianò R; Branca G; Parisi C; Paparo D; Parisi A
Ultrastruct Pathol; 2011 Apr; 35(2):66-71. PubMed ID: 21299346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
